Objective:
To review the role of selective laser trabeculoplasty (SLT) in glaucoma management and its impact on patient quality of life.
Key Findings:
- SLT is effective for open-angle and secondary glaucomas, supported by clinical evidence.
- Quality of life worsens with visual field loss, as shown in the Los Angeles Latino Eye Study.
- DSLT shows minimal differences in IOP change compared to SLT, indicating comparable efficacy.
- Patient preferences lean towards drops over drug delivery systems, highlighting the importance of patient choice.
Interpretation:
SLT and DSLT provide effective options for managing glaucoma while considering patient quality of life and treatment preferences.
Limitations:
- Avoidance of SLT in patients with cataract, corneal edema, or low IOP, which may limit treatment options.
- Potential efficacy trade-off between SLT and DSLT, necessitating further research.
Conclusion:
SLT and DSLT are valuable tools in glaucoma management, reducing treatment burden and improving patient outcomes.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
